Drug utilization studies among anti-epileptic agents
Vincze, Z.
Acta Pharmaceutica Hungarica 53(4): 159-166
1983
ISSN/ISBN: 0001-6659 PMID: 6637498 Document Number: 206963
Document emailed within 1 workday
Related Documents
Foletti, G.B. 2000: Clinical utilization of new anti-epileptic agents Revue Medicale de la Suisse Romande 120(9): 703-707Lumholtz, I.B. 1981: Drug information: agents for the treatment of arrhythmias. Therapeutic main group: anti-arrhythmia agents. 16. (3). Anti-arrhythmia agents with action on ventricular arrhythmias Sygeplejersken 81(2): 15
Takemoto, T.; Yanai, H. 1988: Drug administration schedule of anti-ulcer agents to prevent recurrence of peptic ulcer; problems on standardization of the appropriate time for the withdrawal of anti-ulcer agents Nihon Rinsho. Japanese Journal of Clinical Medicine 46(1): 133-139
Choonara, I. 2018: Anti-Epileptic Drug Toxicity in Children Children 5(5)
O'Donoghue, M.F.; Sander, J.W. 1997: How rational is current anti-epileptic drug treatment? Revue Neurologique (Paris) 153(Suppl): S25-S28
Lumholtz, I.B. 1980: Drug information: agents for the treatment of arrhythmias. Therapeutic main group: anti-arrhythmia agents. 14. Digitalis glycosides Sygeplejersken 80(50): 13
Boudin, G.; Guillard, A.; Pépin, B.; Fabiani, J.M. 1972: Our experience with a new anti-epileptic drug. Clonazepan, Ro 05 4023. Apropos of 71 cases Annales de Medecine Interne 123(6): 617-621
Salas-Puig, J. 2000: Rational anti-epileptic polytherapy. Drug interactions and choice of treatment Revista de Neurologia 30(9): 886-889
Tian, S.L.; Zhao, S.W.; Zhu, A.T.; Fang, Y.; Li, K.Q. 1993: Studies on anti-tumor agents. I: Synthesis and anti-cancer activity of amino acid derivatives of norcantharidin Yao Xue Xue Bao 28(11): 870-875
Nakamura, H.; Kadokawa, T.; Nakatsuji, K.; Nakamura, K. 1970: Pharmacological studies of a new anti-inflammatory drug, 1-phenylsulfonyl-5,5-diphenylhydantoin (PC-796) in experimental animals. I. Anti-inflammatory, analgesic and anti-pyretic activity Arzneimittel-Forschung 20(8): 1032-1046
Uppal, R.; Singh, A.; Sharma, P.L.; Wahi, P.L. 1987: Drug utilization studies in cardiology International Journal of Clinical Pharmacology Therapy and Toxicology 25(4): 214-215
Weiss-Simon, C.; Spangenberg, G.; Michel, D. 1980: Anti-arrhythmic agents. 2. Special anti-arrhythmic effect, known drug interactions Fortschritte der Medizin 98(15): 569-572
Moore, N.; Verschuren, X.; Montout, C.; Callens, J.; Kong, S.X.; Bégaud, B. 2000: Excess costs related to non-steroidal anti-inflammatory drug utilization in general practice Therapie 55(1): 133-136
Gomollón, F.; López, S.G.ía. 2008: Treatment with anti-TNFalpha agents in Crohn's disease: what drug we have to use and when? Acta Gastroenterologica Latinoamericana 38(2): 133-145
Kalburova, F.; Robeva, R.; Minkova, V.; Belovezhdov, N. 1991: Drug disease related to the use of nonsteroidal anti-inflammatory agents Vutreshni Bolesti 30(1): 83-86
Inoue, A. 2015: Report of serious adverse drug reaction induced by anti-cancer agents Nihon Rinsho. Japanese Journal of Clinical Medicine 73 Suppl. 2: 67-72
Johns, B.; Baruwa, E. 2016: The effects of decentralizing anti-retroviral services in Nigeria on costs and service utilization: two case studies Health Policy and Planning 31(2): 182-191
Knipping, W. 1980: Problems of evaluating rare adverse drug reactions using as an example agranulocytosis induced by anti-arrhythmia agents Medizinische Klinik 75(3): 108-115
Qamar, N.; Sultan, H.; Raheel, A.; Ashfaq, M.; Azmat, R.; Naz, R.; Lateef, M.; Khan, K.Mohammed.; Arshad, T. 2019: Heterochelates of metals as an effective anti - Urease agents couple with their docking studies Pakistan Journal of Pharmaceutical Sciences 32(3 ): 1179-1183
Salmon, J.; Levêque, D.; Peter, J.D.; Cavalier, A.; Elkhaïli, H.; Salmon, Y.; Kaltenbach, G.; Monteil, H.; Jehl, F. 1996: Model of a miniature pig catheterized for pharmacokinetic and pharmacodynamic studies of anti-infective agents Pathologie-Biologie 44(5): 375-378